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Background/aim: The 2009 influenza A (H1N1) pandemic caused mild to severe illnesses and led to death in some cases. In this study,
we aimed to evaluate the relationship between the serum D-dimer levels, CURB-65 scores, and the severity of pneumonia among
patients with H1N1 infections.
Materials and methods: Sixty-eight patients who had probable H1N1 infections were evaluated by clinical, radiological, and laboratory
methods. The H1N1 strain was specified by reverse transcription-polymerase chain reaction. Of 55 patients diagnosed with pneumonia,
18 exhibited H1N1 positivity and 37 patients did not.
Results: CURB-65 scores of pneumonia patients with H1N1 (group 1) were higher than those of patients without H1N1 (group 2) (P =
0.02). The D-dimer levels of group 1 were higher than those of group 2 (P = 0.001). Moreover, there was a positive correlation between
D-dimer levels and CURB-65 scores in patients with H1N1-associated pneumonia (P = 0.001; r = 0.89).
Conclusion: Increased D-dimer levels were observed in pneumonia patients with H1N1 infection, which predicted the severity of
pneumonia.
Key words: H1N1, pneumonia severity index, pneumonia, D-dimer

1. Introduction
In 2009, the influenza-A H1N1 strain (H1N1) caused
diseases ranging from influenza-like illness to pneumonia,
which led to acute respiratory distress syndrome (ARDS).
The patients with influenza-like illnesses were admitted to
health care units and cough, headache, and fatigue were
the prominent symptoms, especially among young adults.
However, pneumonia patients that were hospitalized in
the clinics or intensive care units (ICUs) were generally
infants or adults older than 65 years of age (1–3). For all
that, severe H1N1 pneumonia also affected some young
adults without any underlying comorbidities in both the
United States and Turkey (4).
H1N1 patients in critical condition were transported
to ICUs in the 2009 pandemic alert (4,5). Patients who
developed acute respiratory failure were followed up with
the best of care and cautions (6,7). Some of the patients
were young and frequently did not have any accompanying
health problems. Physicians had to diagnose and treat the
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infection immediately and evaluate the severity of the
illness in order to prevent acute respiratory progression
and possible fatality. Therefore, investigators were in need
of new prognostic tools.
The Pneumonia Severity Index, or CURB-65, was
reported to be effective in assessment of the severity of
community-acquired pneumonia (CAP). However, it is
not clear whether these evaluation scales are sufficient
to assess the severity of pneumonia with H1N1 infection.
Thus, we investigated an indicator in order to assess the
severity of pneumonia in H1N1-positive patients (8).
Serum D-dimer values may increase in inflammatory
conditions, such as pneumonia, sepsis, and septic shock
(3,8). We hypothesized that D-dimer levels might be used
as an assessment tool to evaluate the severity of pneumonia.
In this study, we aimed to assess the relationship between
CURB-65 scores and serum D-dimer levels in evaluating
the severity of pneumonia among patients infected with
H1N1. In this way, we planned to evaluate if the serum
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D-dimer values and CURB-65 scores reflected the
prognosis of pneumonia in H1N1-positive patients.
2. Materials and methods
2.1. Patients
The study was conducted in the Ankara Atatürk Research
and Training Hospital during the 2009 pandemic. Seventyfive patients with a high probability of H1N1 infection were
evaluated. The study protocol was approved by the ethical
committee of our institution. The study was designed as
retrospective cohort.
Patients who had pulmonary embolism, malignancy,
chronic renal failure, deep venous thrombosis, and
hematologic disorders were excluded from the study.
Those that were infected after the confirmation of the
H1N1 infection were also excluded.
The following data were recorded: age, sex, duration of
the symptoms (in days), fever, C-reactive protein (CRP),
sedimentation rate, white blood cell counts, platelet counts,
existence of monocytosis, existence of leukocytosis,
median D-dimer levels (reference serum D-dimer values:
0–500 ng/mL), CURB-65 scores, comorbid illnesses, and
radiological findings.
Nasopharyngeal swab samples were taken from all of
the patients. H1N1 was diagnosed via real-time polymerase
chain reaction (RT-PCR) assay as recommended by the
World Health Organization (WHO) (4,9). The chest X-rays
were evaluated by a radiologist and a pulmonologist.
The clinical, radiological, and laboratory findings were
evaluated by the pulmonologist.
A suspected case was defined as a case with at least
one of the following symptoms: a temperature ≥37.5 °C,
sore throat, cough, rhinorrhea, or nasal congestion. A
confirmed case was defined by a positive result of a RTPCR assay.
Patients with pneumonia were divided into two
groups: H1N1-positive cases (group 1) and H1N1-negative
cases (group 2).
Acute infections of the lung parenchyma, with
symptoms such as cough, sputum, breathlessness,
infiltration on a chest X-ray, and crackling during chest
examination were defined as CAP according to the
Infectious Diseases Society of America criteria (10).
The CURB index, as defined by the British Thoracic
Society guidelines, was used to evaluate the severity of
pneumonia. Criteria were: confusion of new onset, serum
urea >7 mmol/L, respiratory rate ≥30/min, and systolic
blood pressure <90 mmHg, or diastolic blood pressure
≤60 mmHg. Severe pneumonia was defined as at least two
criteria positivity (11).
The CURB index was modified by adding age ≥65. A
CURB-65 score was considered severe when the patients
met three or more of the five variables (12).

2.2. Statistical analysis
Statistical analyses were performed using SPSS 16. In
order to test whether the data were normally distributed,
the Kolmogorov–Smirnov or Shapiro–Wilk tests were
used. To compare groups, Student’s t-test or the Mann–
Whitney U-test were used for continuous variables and
the chi-squared test was used for categorical variables.
Homogeneities of variances were tested through Levene’s
test. Degree of association between continuous and ordinal
variables were calculated by Spearman’s correlation
coefficient and graphed in scatter plots. Frequencies
(percentages), mean ± standard deviation, and median
(interquartile range) were provided as descriptive statistics.
P < 0.05 was considered statistically significant.
3. Results
We evaluated 75 hospitalized patients with symptoms
of the common cold or pneumonia in whom H1N1
infection was suspected via clinical, radiological, or
laboratory methods. H1N1 diagnosis was confirmed by
RT-PCR. Multislice computed tomography of the thorax
was performed for patients with suspected pulmonary
embolism. Subsequently, pulmonary embolism was
diagnosed in 7 of the cases. Moreover, we excluded 13
patients with tracheobronchitis because of the absence
of pneumonia signs and symptoms. A total of 55 patients
consistent with a diagnosis of pneumonia were included
in the study.
According to RT-PCR results, 18 H1N1-positive patients
were classified as group 1 and 37 H1N1-negative patients
were classified as group 2. There were no significant
differences regarding the demographic parameters of
group 1 and group 2 (Table 1). Risk factors associated with
H1N1 were evaluated in all patients. Twenty-seven patients
had chronic obstructive pulmonary disease (COPD), 1
patient had asthma, 2 patients had bronchiectasis, and
1 patient had obstructive sleep apnea syndrome. Fifteen
patients had congestive heart failure, 7 patients had atrial
fibrillation, and 28 patients had hypertension. Twelve
patients had diabetes mellitus and 16 patients were obese.
The incidence of obesity was significantly higher in group
1 than in group 2 (P = 0.001). However, congestive heart
failure presence was significantly higher in group 2 than
in group 1 (P = 0.04). Other comorbidities were similar
between group 1 and group 2 (P > 0.05). There were no
significant differences in terms of smoking status and
pathogen microorganisms (Table 2) between group 1 and
2 cases (P = 0.25).
Seventy-two percent (n = 13) of group 1 and 56% (n
= 21) of group 2 had multilobar involvement on the chest
X-ray. The radiological difference between the 2 groups
was statistically significant (P < 0.005). There was a positive
correlation between the D-dimer levels and CURB-65
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Table 1. Characteristic features and patient outcomes included in the study.
H1N1-positive cases (n: 18)
Median (min–max)

H1N1-negative cases (n: 37)
Median (min–max)

P

Age

56.5 (17–85)

62.0 (18–88)

0.71

Female/Male

15/3

21/16

0.24

Duration of symptoms (days)

6 (1–15)

11 (1–60)

0.01

Fever

36.9 (37.9–39)

37.0 (36–39.4)

0.91

C-reactive protein (mg/L)

84.5 (4–254)

90.3 (0–209)

0.79

Sedimentation (mm/h)

44.5 (12–140)

26 (0–129)

0.11

White blood cell count (/μL)

7650 (2700–20,800)

12,000 (2700–28,700)

<0.001

White blood cell percent (%)

14

28

0.66

Monocyte count (/μL)

5.7 (1–17)

5.6 (2.3–17)

0.62

Monocyte percent (%)

9

15

0.88

Platelet count (/L)

222 (111–371)

261 (83–461)

0.03

Serum d-dimer level ng/mL

2805 (620–9007)

1160 (17–6295)

0.0001

Curb-65 score

3 (2–5)

2 (2–4)

0.02

Table 2. Pathogen microorganisms in the study group.
Material

Group 1

Blood

Meticillin-resistant Staphylococcus aureus (MRSA)

Sputum, Urine

Streptococcus pneumoniae
Enterobacter cloacae

Sputum
Blood

Group 2

E. coli

Bronchial Lavage

Klebsiella pneumoniae

Urine

Enterobacter aerogenes

Urine

E. coli

Sputum

Streptococcus pneumoniae

Blood

MRSA

Sputum, Urine

Streptococcus pneumoniae

Blood

MRSA

Sputum, Urine

Streptococcus pneumoniae

scores of group 1 cases (P = 0.00; r = 0.89) (Figure 1). The
D-dimer levels in group 1 were higher than those in group
2 [median (IQR): 3420 (4709.50) and 1245 (1637) ng/mL,
respectively; P = 0.001] (Figure 2). CURB-65 scores of
group 1 were higher than those of group 2 [median (IQR):
3 (2) and 2 (1), respectively; P = 0.02] (Figure 3).
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Eight patients required ICU treatment in followup, 5 required mechanic ventilation, and 1 required
hemodialysis. Five (6.6%) of the patients did not survive.
Of those, 4 were confirmed H1N1 cases. The D-dimer
levels of patients that died during follow-up were higher
than those of the survivors (P = 0.001). In addition, the
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Figure 1. The correlation between the D-dimer and CURB-65
scores of H1N1-positive pneumonia patients.
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Figure 2. Serum D-dimer levels in H1N1-positive pneumonia
patients and in H1N1-negative pneumonia patients.
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Figure 3. CURB-65 figures in H1N1-positive pneumonia patients
and with H1N1-negative pneumonia patients.

deceased patients’ CURB-65 scores were significantly
higher than the scores of the survivors (P = 0.001).
Pneumonia cases were sorted into mild and severe
groups according to CURB-65 scores. CURB-65 scores
of 1–2 were defined as mild pneumonia, and scores of
over 2 defined as severe pneumonia. Thirty-three patients
were diagnosed with mild pneumonia and 22 patients
with severe pneumonia. There were 12 (36.2%) patients
with H1N1-negative severe pneumonia. However, while
10 (58.8%) H1N1-positive patients had severe pneumonia,
8 (41.2%) H1N1-positive patients had mild pneumonia.
We analyzed CURB-65 scores and age, white blood
cell count, CRP count, and serum D-dimer values by
regression analysis. Only serum D-dimer values were
related to the severity of pneumonia (risk ratio: 1.002, 95%
confident interval; 1.001–1.004: P = 0.001). The D-dimer
levels of severe pneumonia were higher than those of
mild pneumonia (4134 and 1160 ng/mL respectively; P
= 0.001). We did not define the relation between serum
D-dimer values and CRP (P > 0.05).
4. Discussion
In this study, we demonstrated that D-dimer levels in
patients with pneumonia and H1N1 positivity were higher
than those in the H1N1-negative group. There was a positive
correlation between the D-dimer levels and CURB-65
scores in patients with H1N1- positive pneumonia.
The H1N1 virus infection originated from North
America in April 2009 and rapidly spread worldwide in the
following months. Before the WHO declared a pandemic
due to H1N1, the adenovirus was frequently isolated in
adults. After the WHO emphasized the pandemic, reported
cases reached a peak in June 2009. Patients with H1N1
infections had mostly respiratory signs and symptoms in
Turkey. The clinical spectrum of illness has been reported
as ranging from upper respiratory tract infection to ARDS
in patients with H1N1 infection in a previous study (9). The
patients in our study reflected a clinical spectrum similar
to that mentioned in the literature.
In this study, the most common symptoms were
recorded as cough (69.5%) and fever (67.4%), similar to
a previous study (9). Moreover, the median length of time
duration of positive RT-PCR was 6 days, which is the same
as Cao et al.’s study. We determined that the admission
period to a hospital in group 2 was longer than that of
group 1.
Serum D-dimer values indicate fibrin turnover in
the body (13). Intraalveolar fibrin can be deposited
during inflammatory lung diseases. Thus, increased
serum D-dimer levels reflect the severity of disease. It
was determined to be higher in pneumonia patients who
required ICU treatment than in CAP patients (14).
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It was reported in previous studies that D-dimer
levels were correlated with the mortality and the need
for ICU admission in patients with CAP (15–17). Two
other studies indicated an association between D-dimer
levels and pneumonia severity index class (18,19). It
was revealed that the CURB-65 pneumonia score is a
predictor of 30-day mortality in patients with methicillinresistant Staphylococcus aureus (MRSA) pneumonia (20).
In the current study, D-dimer levels and the CURB-65
pneumonia scores were found to be higher in 5 of the
deceased patients than in the survivors. For this reason, it
was speculated that serum D-dimer levels and CURB-65
pneumonia scores are important in evaluating pneumonia’s
severity.
H1N1–CAP has a high complication rate. Therefore,
early estimation of the diagnosis and prompt treatment
are lifesaving. Appropriate clinical evaluation, effective
antiviral and antibacterial treatment, and monitoring the
pneumonia’s severity are critical for survival (1,21–23).
For these reasons, while we were monitoring CAP patients
with H1N1 infections, it was important to evaluate the
severity of pneumonia. In the literature, there are rare
studies evaluating pneumonia severity with CURB-65
scoring in order to predict the severity of pneumonia with
H1N1 infection. No correlation was found between CURB65 scoring and the severity of pneumonia in their study
(24). In the current study, we showed that both CURB-65
scores and serum D-dimer levels were correlated with the
severity of pneumonia in H1N1-positive patients. Five of
the patients (6.6%) died in our study. D-dimer levels of
these patients were higher than the levels of the patients
who survived. D-dimer levels could reflect the prognosis
in this population.

Both MRSA and Streptococcus pneumoniae were
frequently detected in pneumonia patients with H1N1
infections, similar to the literature. However, these
microorganisms were not observed in patients without
H1N1 infection.
Our study had some limitations. First, this study is
retrospectively designed. It may not be enough to evaluate
the severity of pneumonia with other parameters. Second,
we did not apply any other severity indices or compare
CURB-65 with other scoring systems. Third, we did not
record the follow-up serum D-dimer values.
In light of the current results, higher D-dimer levels
among patients with H1N1-associated pneumonia
compared with the other cases were determined in this
study. The D-dimer levels correlated with CURB-65 scores
of the patients. In conclusion, increased D-dimer levels
were detected in the large majority of pneumonia patients
with H1N1, and it was observed that they could even be
higher in mortal cases and could predict the severity of
pneumonia. We conclude that serum D-dimer levels might
be an important marker in the follow-up treatment of H1N1positive pneumonia patients. Although serum D-dimer
value is a nonspecific marker, a high D-dimer value could
indicate a high grade of inflammation in pneumonia. When
the patients were admitted to the hospital, high D-dimer
values indicated to the clinician that a more aggressive
approach was necessary. The importance of CURB-65
scores in the evaluating of severity of pneumonia is known
in the literature. Furthermore, high CURB-65 scores
might be able to predict fatality and poor prognosis in
H1N1-positive pneumonia patients. As a result, clinicians
might follow up and treat patients exhibiting high serum
D-dimer levels and CURB-65 scores on admission with an
aggressive approach in clinical practice.
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